Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jun:131:162-165.
doi: 10.1016/j.ijid.2023.04.007. Epub 2023 Apr 8.

Disseminated mycobacterial infections after tumor necrosis factor inhibitor use, revealing inborn errors of immunity

Affiliations
Case Reports

Disseminated mycobacterial infections after tumor necrosis factor inhibitor use, revealing inborn errors of immunity

Jacqueline D Squire et al. Int J Infect Dis. 2023 Jun.

Abstract

Tumor necrosis factor-a inhibitors can be associated with increased risk of infections, particularly reactivation of latent tuberculosis or nontuberculous mycobacterium (NTM). However, because disseminated NTM is rare, inborn errors of immunity should be considered. We present three patients with disseminated NTM after tumor necrosis factor-a inhibitor use who were found to have inborn errors of immunity.

Keywords: Immunodeficiency; Inborn errors of immunity; Infliximab; Mycobacteria; TNF inhibitor.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors have no competing interests to declare.

Figures

Figure 1.
Figure 1.
Clinical Images of Mycobacterium Avium Complex Infections from Cases A) Patient 1 skin lesions, initial biopsy showed lobular panniculitis with suppurative necrosis. B) Patient 1 large right perihilar pulmonary opacity with worsening mediastinal adenopathy C) Patient 2 PET scan demonstrating hypermetabolic right cervical neck and extensive abdominopelvic lymphadenopathy, right parietal scalp lesion, and hypermetabolic activity in lytic L1 lesion

References

    1. Roach DR, et al., TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol, 2002. 168(9): p. 4620–7. - PubMed
    1. Keane J, et al., Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med, 2001. 345(15): p. 1098–104. - PubMed
    1. Wallis RS, et al., Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis, 2004. 38(9): p. 1261–5. - PubMed
    1. Uzel G, et al., Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. Clin Infect Dis, 2010. 51(12): p. 1429–34. - PMC - PubMed
    1. Conrad A, et al., Infections in Patients with Chronic Granulomatous Disease Treated with Tumor Necrosis Factor Alpha Blockers for Inflammatory Complications. J Clin Immunol, 2021. 41(1): p. 185–193. - PubMed

Publication types

MeSH terms

Substances